Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer

被引：3
|
作者：
Zapatero, A. [1 ]
Guerrero, A. [2 ]
Maldonado, J. [3 ]
Alvarez, A. [4 ]
Gonzalez San Segundo, C. [4 ]
Cabeza Rodriguez, M. [4 ]
Macias, V. [5 ]
Pedro-Olive, A. [6 ]
Casas, F. [7 ]
Boladeras, A. [8 ]
Martin de Vidales, C. [1 ]
Vazquez de la Torre, M. [9 ]
Calvo, F. A. [4 ]
机构：
[1] Hosp Univ La Princesa, Madrid, Spain
[2] Hosp Son Dureta, Palma De Mallorca, Spain
[3] Hosp Valle De Hebron, Barcelona, Spain
[4] Hosp Univ Gregorio Maranon, Madrid, Spain
[5] Hosp Univ Salamanca, Hosp Gen Catalunya, Salamanca, Spain
[6] Clin Plato, Barcelona, Spain
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] Inst Catala Oncol, Barcelona, Spain
[9] Hosp Meixoeiro, Vigo, Spain
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.06.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL-02
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [1] Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable intermediate- and high-risk prostate cancer.
    Dyer, Michael A.
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [2] Significance of androgen-deprivation therapy for intermediate- and high-risk prostate cancer treated with high-dose radiotherapy: A literature review
    Aizawa, Rihito
    Ishikawa, Hitoshi
    Kato, Manabu
    Shimizu, Shosei
    Mizowaki, Takashi
    Kohjimoto, Yasuo
    Hinotsu, Shiro
    Hara, Isao
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1068 - 1079
  • [3] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Cagney, Daniel N.
    Dunne, Mary
    O'Shea, Carmel
    Finn, Marie
    Noone, Emma
    Sheehan, Martina
    McDonagh, Lesley
    O'Sullivan, Lydia
    Thirion, Pierre
    Armstrong, John
    BMC UROLOGY, 2017, 17
  • [4] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Daniel N. Cagney
    Mary Dunne
    Carmel O’Shea
    Marie Finn
    Emma Noone
    Martina Sheehan
    Lesley McDonagh
    Lydia O’Sullivan
    Pierre Thirion
    John Armstrong
    BMC Urology, 17
  • [5] A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer
    Hamid, Muhammad
    Heilbrun, Lance K.
    Maier, Jordan
    Devisetty, Kiran
    Connolly, Irene
    Kaufman, Isaac
    Dobson, Kimberlee
    Herroon, Mackenzie K.
    Smith, Daryn
    Sampson, Sandra
    Podgorski, Izabela
    Heath, Elisabeth I.
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (04)
  • [6] High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapy
    Bolla, Michel
    Verry, Camille
    Long, Jean-Alexandre
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 349 - 354
  • [7] Late Side Effects in Men With Intermediate- and High-Risk Prostate Cancer Treated With High-Dose Radiation Therapy and Androgen Deprivation (DART 01/05): Secondary Endpoints From a Phase 3 Clinical Trial
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    Alvarez, A.
    San Segundo, C. Gonzalez
    Cabeza, M.
    Casas, F.
    Pedro Olive, A.
    Boladeras, A.
    Calvo, F. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S105 - S105
  • [8] Short-Term Androgen Deprivation Therapy and High -Dose Radiotherapy in Intermediate- and High -Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial
    Demogeot, N.
    Sargos, P.
    Sahki, N.
    Guerif, S.
    De Crevoisier, R.
    Calais, G.
    Hannoun-Levi, J. M.
    Bouche, G.
    Hennequin, C.
    Cretin, J.
    Belkacemi, Y.
    Khalifa, J.
    Azria, D.
    Bauer, N.
    Pommier, P.
    Pommier, P.
    Simon, J. M.
    Leger, C.
    Beckendorf, V.
    Dubray, B. M.
    Supiot, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S4 - S5
  • [9] Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991
    Bolla, Michel
    Maingon, Philippe
    Carrie, Christian
    Villa, Salvador
    Kitsios, Petros
    Poortmans, Philip M. P.
    Sundar, Santhanam
    van der Steen-Banasik, Elzbieta M.
    Armstrong, John
    Bosset, Jean-Francois
    Herrera, Fernanda G.
    Pieters, Bradley
    Slot, Annerie
    Bahl, Amit
    Ben-Yosef, Rahamim
    Boehmer, Dirk
    Scrase, Christopher
    Renard, Laurette
    Shash, Emad
    Coens, Corneel
    van den Bergh, Alphonsus C. M.
    Collette, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15) : 1748 - +
  • [10] High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features
    C Vargas
    A Martínez
    R Galalae
    J Demanes
    A Harsolia
    L Schour
    N Nuernberg
    J Gonzalez
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 245 - 253
12345